Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series
Abstract
Although immune checkpoint blockade has demonstrated limited effectiveness against ovarian cancer, subset analyses from completed trials suggest possible superior efficacy in the clear cell carcinoma subtype.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 11, 2022
- Source ID
- 10.1136/ijgc-2022-003430
Entities
People
- Antonio Marra
- Beryl L. Manning-Geist
- Britta Weigelt
- Claire F. Friedman
- Dennis S. Chi
- Dmitriy Zamarin
- Jason A. Konner
- Oliver Zivanovic
- Rajmohan Murali
- Sushmita Gordhandas
- Tiffany Y Sia
- Travis J. Hollmann
- Ying L. Liu
Organizations
- National Cancer Institute
- United States Department of Defense